Analysis of Average Manufacturer Prices of New Drugs Approved in the United States (1990-2012)

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Trends in Approvals and Prices of Oncology Drugs in the United States (1990-2013)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Prices Analysis of Osteoporosis Drugs Marketed in the United States (1988-2014)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Php65 - Analysis of Icer-Estimated Value-Based Prices and Potential Discounts for Drugs in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Section 1. Fluorine - Containing Drugs for Human Use Approved by FDA in the United States

English

Tularemia—United States, 1990-2000

JAMA - Journal of the American Medical Association
Medicine
2002English

Methylphenidate in the United States, 1990 Through 1995.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Capital Punishment in the United States, 1973-1990

1993English

Prices of Lilies for 1928 Delivered in the United States /

1928English

Filgrastim-SNDZ Debuts as the First Biosimilar Approved in United States

Journal of Community and Supportive Oncology
OncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy